These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20442585)

  • 1. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
    Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
    Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX1 methylation as a potential biomarker for cervical cancer screening.
    Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
    Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.
    Luo H; Lian Y; Tao H; Zhao Y; Wang Z; Zhou J; Zhang Z; Jiang S
    BMC Cancer; 2024 Sep; 24(1):1171. PubMed ID: 39304838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
    Wang ZM
    Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
    J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of PAX1 Methylation Analysis by MS-HRM in the Triage of Atypical Squamous Cells of Undetermined Significance.
    Li SR; Wang ZM; Wang YH; Wang XB; Zhao JQ; Xue HB; Jiang FG
    Asian Pac J Cancer Prev; 2015; 16(14):5843-6. PubMed ID: 26320460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
    Gao Y; Zi D; Liang W; Qiu F; Zheng J; Xiao X; Jiang E; Xu Y
    Acta Cytol; 2024; 68(2):137-144. PubMed ID: 38527422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.
    Kang WD; Kim CH; Cho MK; Kim JW; Kim YH; Choi HS; Kim SM
    Int J Gynecol Cancer; 2009 Jul; 19(5):924-8. PubMed ID: 19574786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
    Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
    Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time colorimetric detection of DNA methylation of the
    Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
    Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
    Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular progression to cervical precancer, epigenetic switch or sequential model?
    Nedjai B; Reuter C; Ahmad A; Banwait R; Warman R; Carton J; Boer S; Cuzick J; Lorincz AT
    Int J Cancer; 2018 Oct; 143(7):1720-1730. PubMed ID: 29679470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
    Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating PAX1 methylation for cervical cancer screening triage in non-16/18 hrHPV-positive women.
    Huang M; Wang T; Li M; Qin M; Deng S; Chen D
    BMC Cancer; 2024 Jul; 24(1):913. PubMed ID: 39080593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
    Lu Y; Wu H; Fu K; Shen Y; Li L; Liao Z; Liu Y; Kang Y; Zhang Y
    Clin Epigenetics; 2024 Jun; 16(1):77. PubMed ID: 38849868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.